Quality standard
Quality statements
Quality statements
Statement 1 People who are at increased risk of hepatitis B infection are offered testing and vaccination.
Statement 2 People who test positive for hepatitis B surface antigen (HBsAg) are referred to specialist care for further assessment.
Statement 3 Pregnant women who are identified as hepatitis B surface antigen (HBsAg)-positive at antenatal screening are assessed by a specialist within 6 weeks of receiving the screening test result.
Statement 4 Babies born to hepatitis B surface antigen (HBsAg)-positive mothers receive a complete course of hepatitis B vaccination and, at age 12 months, receive a blood test for hepatitis B infection.
Statement 5 People with chronic hepatitis B infection, and their family members or carers (if appropriate), are offered a personalised care plan outlining the proposed treatment and long-term management of their infection.
Statement 6 People with chronic hepatitis B infection who do not meet the criteria for antiviral treatment are monitored regularly at intervals determined by their infection status and age.
Statement 7 Adults with chronic hepatitis B infection who have significant liver fibrosis or cirrhosis are offered 6-monthly surveillance testing for hepatocellular carcinoma.